-
Five Contemporary Drug Launch Phenotypes Every Pharma Marketer Should Know
Sales and marketing efforts behind a new drug launch can vary significantly by brand and this post highlights five distinct...
-
Industry-Sponsored Speaking Tracker
Our tracker provides a monthly summary of fees paid U.S. physicians who have served as a product speaker based…
-
U.S. Sales Force Estimator
Our sales force sizing tool provides an annual estimate of deployed resources based on company-reported data.
-
Lilly’s endocrinology-centric launch of Trulicity into T2D
The Type 2 diabetes (T2D) market is composed of dozens of agents that span a multitude of classes (e.g., GLP-1, SGLT2, and...
-
Target specialty mix in prostate cancer: Urology vs. Oncology
While patients with advanced stage cancer are generally treated by hem/oncs or med oncs there are several tumor types that involve...
-
Location of top research centers for checkpoint inhibitors
Immunotherapies targeting CTLA-4 and PD-1 have recently garnered a lot of well-deserved press, as they continue to radically improve the outcomes of...
-
Gilead’s orchestrated HCV market development activity
Gilead’s HCV franchise had a massive 2014, generating $12.4B in revenue for the full calendar year. Gilead was able...
-
Benchmarking paid speaker fees by opinion leader specialty
Sponsored speaker events remain an effective component of pharmaceutical marketing, particularly in building awareness around a new drug launch or clinical data...
-
Characterizing clinical researcher alignment in Florida
Cancer research is accelerating at a rapid pace and has begun to deliver clinically, with several breakthrough therapies recently...
-
Tracking Roche’s next-gen anti-CD20 launch
Rituxan (rituximab) is an incredibly successful drug for Roche, generating billions of dollars across multiple indications each year. Roche’s...
-
Neurologist coverage within the competitive MS market
Multiple Sclerosis (MS) is one of the most competitive specialty markets we track, as a number of sophisticated players...
-
Average frequency of paid interactions across specialty areas
We’ve calculated the average number interactions per physician across several specialty areas by leveraging the 15M+ paid interactions tracked by the...
Five Contemporary Drug Launch Phenotypes Every Pharma Marketer Should Know
MDDetails